Michael Ohlmeyer

Atux Iskay Group LLC

NIH Rank #5127
  • Early Career

NIH Funding · FY2024

Total Funding
$2M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#5,127
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2M across 2 grants · National rank #5127.

Top grants by award amount

Michael Ohlmeyer's NIH grant portfolio, ranked by award amount.

  • 2R44AG071040-02R44
    Direct protein phosphatase 2A (PP2A) activators as novel Alzheimer’s Disease (AD) therapeutics
    $1.7M
    award amount
  • 75N91024C00009-0-9999-1N43
    SBIR CONCEPT AWARD - THERAPEUTICS - SULFONYL-UREA AND SULFONAMIDE PP2A ACTIVATORS AS MYCN AMPLIFIED NEUROBLASTOMA (NBL) THERAPEUTICS
    $355K
    award amount

Affiliation

Institutions that have administered grants for Michael Ohlmeyer.

Affiliated with Atux Iskay Group LLC (NJ).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Atux Iskay Group LLC
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #5127